B. Metzler Seel. Sohn & Co. Ag Illumina, Inc. Transaction History

B. Metzler Seel. Sohn & Co. Ag

  • $10 Billion
  • Q3 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Illumina, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 5,441 shares of ILMN stock, worth $740,084. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,441
Previous 5,441 -0.0%
Holding current value
$740,084
Previous $567,000 25.04%
% of portfolio
0.01%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$101.05 - $133.57 $275,866 - $364,646
-2,730 Reduced 33.41%
5,441 $567,000
Q4 2023

Feb 13, 2024
SELL
$92.79 - $142.53 $387,212 - $594,777
-4,173 Reduced 33.81%
8,171 $1.14 Million
Q3 2023

Nov 13, 2023
BUY
$128.91 - $192.44 $159,074 - $237,470
1,234 Added 11.11%
12,344 $1.69 Million
Q2 2023

Aug 11, 2023
BUY
$183.43 - $232.67 $130,051 - $164,963
709 Added 6.82%
11,110 $2.08 Million
Q1 2023

May 10, 2023
BUY
$193.75 - $232.55 $15,500 - $18,604
80 Added 0.78%
10,401 $2.42 Million
Q4 2022

Feb 13, 2023
SELL
$187.24 - $242.74 $313,814 - $406,832
-1,676 Reduced 13.97%
10,321 $2.09 Million
Q3 2022

Nov 14, 2022
SELL
$177.23 - $227.44 $27,470 - $35,253
-155 Reduced 1.28%
11,997 $2.29 Million
Q2 2022

Aug 12, 2022
SELL
$181.58 - $368.0 $64,097 - $129,904
-353 Reduced 2.82%
12,152 $2.24 Million
Q1 2022

May 10, 2022
BUY
$303.87 - $423.8 $100,580 - $140,277
331 Added 2.72%
12,505 $4.37 Million
Q4 2021

Feb 11, 2022
BUY
$347.28 - $421.83 $4.23 Million - $5.14 Million
12,174 New
12,174 $4.68 Million

Others Institutions Holding ILMN

# of Institutions
900
Shares Held
137M
Call Options Held
1.22M
Put Options Held
1.43M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email